3 HMO Stocks to Watch Amid Nurse Shortages, High Tech Costs
The Medical-HMO industry rides on steady premium flows resulting from a growing customer base and contract wins. However, industry headwinds like elevated technology costs and workforce shortages remain concerns.
Centene & HMHB Hawaii Expand Partnership for Maternal Care
CNC's Ohana Health Plan and HMHB Hawaii expand maternal care, enhancing support for mothers and babies through strategic investment and community partnerships.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Centene: A Leader In Government-Sponsored Insurance And Its Prospects
Centene's business transformation and strategic focus on core segments have led to increased operational marginality, despite losing 3.3 million Medicaid customers in 2024. I assign a "Buy" rating to Centene, with a fair valuation of $73 per share, indicating a 27% potential increase from the current price. The company's competitive advantage lies in its focus on Medicaid and Medicare, but it faces risks from regulatory changes and strong competition.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Centene's Meridian Unit Secures a D-SNP Contract in Illinois
CNC's Meridian Health Plan wins a D-SNP contract in Illinois, expanding enhanced managed care for Medicare-Medicaid-eligible individuals. The deal is likely to boost Centene's foothold and membership base in the state.
Centene Corporation Is Resilient And Will Thrive
Centene Corporation is a buy opportunity under $60, with a strong valuation and momentum, despite market volatility and economic concerns. The company reported strong Q4 '24 results, with EPS of $0.80 and FY '24 EPS of $7.17, and management raised 2025 revenue guidance by $4 billion. Risks include potential Medicaid and Medicare enrollment cuts, program pullbacks, and cash flow concerns for the company, but we expect management to navigate these challenges.
Why Is Centene (CNC) Down 2.9% Since Last Earnings Report?
Centene (CNC) reported earnings 30 days ago. What's next for the stock?
Centene Q4 Earnings Beat Estimates on Membership Growth, 2025 View Up
CNC now projects premium and service revenues of $158-$160 billion in 2025.
Centene Corporation (CNC) Q4 2024 Earnings Conference Call Transcript
Centene Corporation (NYSE:CNC ) Q4 2024 Earnings Conference Call February 4, 2025 8:30 AM ET Company Participants Jennifer Gilligan - Senior Vice President, Finance and Investor Relations Sarah London - Chief Executive Officer Andrew Asher - Executive Vice President and Chief Financial Officer Conference Call Participants Josh Raskin - Nefron Research Justin Lake - Wolfe Research Stephen Baxter - Wells Fargo A.J. Rice - UBS Adam Ron - Bank of America Sarah James - Cantor Fitzgerald Scott Fidel - Stephens Lance Wilkes - Bernstein Michael Ha - Baird George Hill - Deutsche Bank David Windley - Jefferies John Stansel - J.P.
Insurance Firm Centene Sees Q4 Revenue Boost, Sticks To Annual Forecast
On Tuesday, Centene Corporation CNC reported fourth-quarter sales of $40.80 billion. That's up 3.41% year-over-year, beating the consensus of $39.13 billion.
Centene (CNC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Centene (CNC) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
